Antibody Therapy and Diagnosis of Alzheimer's Disease (AD)
Alzheimer's Disease (AD) is the main neurodegenerative disease worldwide affecting more than 29 Mill. people. By 2050 the prevalence will quadruple, by thich time 1 in 85 persons worldwide will be living with AD. AD still features high growth potential and room for further innovation due to the huge worldwide growth of the number of patients and the lack of efficacious drugs.
Scientists at the University of Göttingen developed a novel proprietary Antibody for the Therapy and/or Diagnosis of Alzheimer's Disease (AD). HALLMARKS * New proprietary Antibody against Alzheimer's Disease (9D5 mouse anti human). * Antibody selectively targets pyro-Glu-Abeta peptide oligomers. * Oligomeric pyro-Glu-Abeta peptides are the triggers of Abeta aggregation and plaque formation, thus of AD. * Intraneuronal pyro-Glu-Abeta 3-42 peptide is toxic and triggers neurodegeneration and lethal neurological deficits. * To be used for sporadic AD and most familiar AD forms. * Blood ELISA test for diagnosis achieved. * In vivo proof of concept successfully achieved. USES (1) Diagnosis * Blood sample. * ELISA quick and easy measurement. * Companion therapeutical efficacy test. (2) Therapeutic * AD therapy based on proprietary antibody. We are now looking for companies, which are interested in licensing, developing and commercializing our approach.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Superradiant atoms could push the boundaries of how precisely time can be measured
Superradiant atoms can help us measure time more precisely than ever. In a new study, researchers from the University of Copenhagen present a new method for measuring the time interval,…
Ion thermoelectric conversion devices for near room temperature
The electrode sheet of the thermoelectric device consists of ionic hydrogel, which is sandwiched between the electrodes to form, and the Prussian blue on the electrode undergoes a redox reaction…
Zap Energy achieves 37-million-degree temperatures in a compact device
New publication reports record electron temperatures for a small-scale, sheared-flow-stabilized Z-pinch fusion device. In the nine decades since humans first produced fusion reactions, only a few fusion technologies have demonstrated…
